 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 October 2001 | Volume 135 Issue 7 | Pages 502-506
Background: Heparin-induced thrombocytopenia is a prothrombotic drug reaction caused by platelet-activating antibodies that recognize complexes of platelet factor 4 and heparin.
Objective: To describe a syndrome termed delayed-onset heparin-induced thrombocytopenia, in which thrombocytopenia and thrombotic events begin 5 or more days after withdrawal of heparin.
Design: Case series.
Setting: Secondary and tertiary care hospitals.
Patients: 12 patients who presented with serologically confirmed, delayed-onset heparin-induced thrombocytopenia, including 6 outpatients presenting after hospital discharge.
Measurements: The platelet serotonin-release assay was used to measure IgG-induced heparin-dependent and heparin-independent platelet activation; an enzyme immunoassay that detects IgG against platelet factor 4–heparin complexes was also used.
Results: Patients with delayed-onset heparin-induced thrombocytopenia presented with thrombocytopenia and associated thrombosis a mean of 9.2 days (range, 5 to 19 days) after stopping heparin therapy. Nine patients received additional heparin, with further decrease in platelet counts. Compared with controls, patients with delayed-onset heparin-induced thrombocytopenia had higher titers of IgG antibodies to platelet factor 4–heparin and greater IgG-induced heparin-dependent and heparin-independent platelet activation.
Conclusions: Delayed-onset heparin-induced thrombocytopenia should be suspected when patients present with thrombocytopenia and thrombosis up to 3 weeks after exposure to heparin. This syndrome could be caused by high titers of platelet-activating IgG induced by heparin.
Author and Article Information
From McMaster University and the Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada.
Acknowledgments: The authors thank Wendy M. Nicholson (Burlington, Ontario), Harold Richter (Boca Raton, Florida), Donald H. Berdeaux (Great Falls, Montana), and M.E. Tweeddale (Toronto, Ontario) for referring four of the patients described in this report.
Grant Support: By the Heart and Stroke Foundation of Ontario (B-3763 and T-4502 [Dr. Warkentin] and T-4404 [Dr. Kelton]).
Requests for Single Reprints: Theodore E. Warkentin, MD, Hamilton Regional Laboratory Medicine Program, Hamilton General Hospital, Hamilton Health Sciences, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada.
Current Author Addresses: Dr. Warkentin: Hamilton Regional Laboratory Medicine Program, Hamilton General Hospital, Hamilton Health Sciences, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada.
Dr. Kelton: Department of Medicine, Room 3W10, McMaster University Medical Centre, Hamilton Health Sciences, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.
Author Contributions: Conception and design: T.E. Warkentin, J.G. Kelton.
Analysis and interpretation of the data: T.E. Warkentin, J.G. Kelton.
Drafting of the article: T.E. Warkentin, J.G. Kelton.
Critical revision of the article for important intellectual content: T.E. Warkentin, J.G. Kelton.
Final approval of the article: T.E. Warkentin, J.G. Kelton.
Provision of study materials or patients: T.E. Warkentin.
Statistical expertise: T.E. Warkentin.
Obtaining of funding: T.E. Warkentin.
Administrative, technical, or logistic support: T.E. Warkentin.
Collection and assembly of data: T.E. Warkentin. BRIEF COMMUNICATION
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  T. E. Warkentin, A. Greinacher, A. Koster, and A. M. Lincoff Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 340S - 380S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Jackson Everett BM, et al. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007;83:592-597 Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2008; 20(1): 102 - 103. [Abstract] [PDF]
|
|
|
|
 |
|
 J. H. Levy, K. A. Tanaka, and M. J. Hursting Reducing Thrombotic Complications in the Perioperative Setting: An Update on Heparin-Induced Thrombocytopenia Anesth. Analg., September 1, 2007; 105(3): 570 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Ahmed, A Majeed, and R Powell Heparin induced thrombocytopenia: diagnosis and management update Postgrad. Med. J., September 1, 2007; 83(983): 575 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and J. W. Eikelboom Who Is (Still) Getting HIT? Chest, June 1, 2007; 131(6): 1620 - 1622. [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Cooney Heparin-induced thrombocytopenia: advances in diagnosis and treatment. Crit. Care Nurse, December 1, 2006; 26(6): 30 - 36. [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin, J.-A. I. Sheppard, C. S. Sigouin, T. Kohlmann, P. Eichler, and A. Greinacher Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia Blood, November 1, 2006; 108(9): 2937 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Levine, D. McCollum, and M. J. Hursting How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia? Chest, September 1, 2006; 130(3): 681 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Arepally and T. L. Ortel Heparin-Induced Thrombocytopenia N. Engl. J. Med., August 24, 2006; 355(8): 809 - 817. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin HIT without (more) heparin Blood, March 15, 2006; 107(6): 2214 - 2215. [Full Text] [PDF]
|
|
|
|
|
|
L. Rauova, L. Zhai, M. A. Kowalska, G. M. Arepally, D. B. Cines, and M. Poncz Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications Blood, March 15, 2006; 107(6): 2346 - 2353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Anticoagulation for cardiopulmonary bypass: is a replacement for heparin on the horizon? J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 515 - 516.
|
|
|
|
 |
|
 A. K. Lilikakis, T. Papapolychroniou, G. Macheras, and E. Michelinakis Thrombocytopenia and Intra-cerebral Complications Associated with Low-Molecular-Weight Heparin Treatment in Patients Undergoing Total Hip Replacement. A Report of Two Cases J. Bone Joint Surg. Am., March 1, 2006; 88(3): 634 - 638. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Jackson, W. J. Neilson, M. Lary, P. Baay, K. Web, and G. P. Clagett Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis After Intraoperative Heparin Anticoagulation: Four Case Reports Vascular and Endovascular Surgery, January 1, 2006; 40(1): 67 - 70. [Abstract] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin Think of HIT Hematology, January 1, 2006; 2006(1): 408 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Prandoni, S. Siragusa, B. Girolami, F. Fabris, and for the BELZONI Investigators Group The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study Blood, November 1, 2005; 106(9): 3049 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-K. Jang and M. J. Hursting When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia Circulation, May 24, 2005; 111(20): 2671 - 2683. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Sanfelippo Heparin-Induced Thrombocytopenia--A Potential Iatrogenic Complication for Patients with Cardiac and Vascular Disease Angiology, May 1, 2005; 56(3): 305 - 309. [Abstract] [PDF]
|
|
|
|
|
|
R. L. Levine Finding Haystacks Full of Needles: From Opus to Osler Chest, May 1, 2005; 127(5): 1488 - 1490. [Full Text] [PDF]
|
|
|
|
|
|
L. Rice Cases of Heparin-Induced Thrombocytopenia Elucidate the Syndrome Chest, February 1, 2005; 127(2_suppl): 21S - 26S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bartholomew Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia Chest, February 1, 2005; 127(2_suppl): 27S - 34S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia Chest, February 1, 2005; 127(2_suppl): 35S - 45S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin Heparin-Induced Thrombocytopenia: Diagnosis and Management Circulation, November 2, 2004; 110(18): e454 - e458. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rice Heparin-Induced Thrombocytopenia: Myths and Misconceptions (That Will Cause Trouble for You and Your Patient) Arch Intern Med, October 11, 2004; 164(18): 1961 - 1964. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Smythe, W. E. Dager, and N. M. Patel Managing Complications of Anticoagulant Therapy Journal of Pharmacy Practice, October 1, 2004; 17(5): 327 - 346. [Abstract] [PDF]
|
|
|
|
|
|
T. E. Warkentin and A. Greinacher Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 311S - 337S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mosen, C. G. Elliott, M. J. Egger, M. Mundorff, J. Hopkins, R. Patterson, and R. M. Gardner The Effect of a Computerized Reminder System on the Prevention of Postoperative Venous Thromboembolism Chest, May 1, 2004; 125(5): 1635 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kannan, R. Ahmed, S. Kale, S. Ahmad, J. Fareed, and R. Saxena Laboratory Diagnosis of Heparin-Induced Thrombocytopenia in Asian Indians as Investigated With Functional and Immunologic Methods Clinical and Applied Thrombosis/Hemostasis, January 1, 2004; 10(1): 51 - 54. [Abstract] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin and A. Greinacher Heparin-induced thrombocytopenia and cardiac surgery Ann. Thorac. Surg., December 1, 2003; 76(6): 2121 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and A. Greinacher Heparin-induced thrombocytopenia and cardiac surgery Ann. Thorac. Surg., August 1, 2003; 76(2): 638 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Girolami, P. Prandoni, P. M. Stefani, C. Tanduo, P. Sabbion, P. Eichler, R. Ramon, G. Baggio, F. Fabris, and A. Girolami The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study Blood, April 15, 2003; 101(8): 2955 - 2959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and R. A. Bernstein Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin N. Engl. J. Med., March 13, 2003; 348(11): 1067 - 1069. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Shah and J. P. Spencer Heparin-Induced Thrombocytopenia Occurring After Discontinuation of Heparin J Am Board Fam Med, March 1, 2003; 16(2): 148 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin Pork or beef? Ann. Thorac. Surg., January 1, 2003; 75(1): 15 - 16. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Francis, G. J. Palmer III, R. Moroose, and A. Drexler Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery Ann. Thorac. Surg., January 1, 2003; 75(1): 17 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin, W. C. Aird, and J. H. Rand Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome Hematology, January 1, 2003; 2003(1): 497 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Alving How I treat heparin-induced thrombocytopenia and thrombosis Blood, January 1, 2003; 101(1): 31 - 37. [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. DeLoughery Thrombocytopenia in Critical Care Patients J Intensive Care Med, November 1, 2002; 17(6): 267 - 282. [Abstract] [PDF]
|
|
Article
